Enlivex Therapeutics Ltd ENLV
NAS: ENLV | ISIN: IL0011319527 14/11/2024
1,080 USD (-8,47%)
(-8,47%)
14/11/2024
Profiel Enlivex Therapeutics Ltd
CEO: Dror Mevorach
Werknemers: 36